Intra-Cellular: 2Q Earnings Snapshot
Aug. 02, 2018
NEW YORK (AP) _ Intra-Cellular Therapies Inc. (ITCI) on Thursday reported a loss of $37.4 million in its second quarter.
The New York-based company said it had a loss of 68 cents per share.
Intra-Cellular shares have risen 43 percent since the beginning of the year. The stock has increased 84 percent in the last 12 months.